Anzahl der Publikationen: 5
Zeitschriftenartikel
Schütz, C.; Inselmann, S.; Saussele, Susanne; Dietz, C. T.; Müller, M. C.; Eigendorff, E.; Brendel, C. A.; Metzelder, S. K.; Brümmendorf, T. H.; Waller, C.; Dengler, J.; Goebeler, M. E.; Herbst, R.; Freunek, G.; Hanzel, S.; Illmer, Thomas; Wang, Y.; Lange, T.; Finkernagel, F.; Hehlmann, Rüdiger; Huber, M.; Neubauer, A.; Hochhaus, Andreas; Guilhot, Joelle; Mahon, F. X.; Pfirrmann, Markus und Burchert, A.
(2018):
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.
In: Leukemia, Bd. 32, Nr. 4
Richter, J.; Mahon, F. X.; Guilhot, J.; Hjorth-Hansen, H.; Almeida, A.; Janssen, J. J.; Mayer, J.; Porkka, K.; Panayiotidis, P.; Olsson-Strömberg, U.; Berger, M. G.; Diamond, J.; Ehrencrona, H.; Kairisto, V.; Polakova, K. Machova; Müller, M. C.; Mustjoki, S.; Hochhaus, A.; Pfirrmann, M. und Saußele, S.
(2016):
Stopping tyrosine kinase inhibitors in a very large cohort of European chronic myeloid leukemia patients: results of the euro-ski trial.
In: Haematologica, Bd. 101: S. 22-23
Burchert, A.; Inselmann, S.; Saußele, S.; Dietz, C. T.; Müller, M. C.; Eigendorff, E.; Brendel, C. A.; Metzelder, S. K.; Brümmendorf, T. H.; Waller, C.; Dengler, J.; Goebeler, M. E.; Herbst, R.; Freunek, G.; Stefan, H.; Illmer, T.; Wang, Y.; Lange, T.; Finkernagel, F.; Hehlmann, R.; Huber, M.; Neubauer, A.; Hochhaus, A.; Guilhot, J.; Mahon, F. X.; Pfirrmann, M. und Schütz, C.
(2016):
Expression of the CTLA-4 ligand CD86 (B7.2) on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in chronic myeloid leukemia.
In: Oncology Research and Treatment, Bd. 39: S. 39
Hasford, Joerg; Pfirrmann, Markus; Shepherd, P.; Guilhot, J.; Hehlmann, R.; Mahon, F. X.; Kluin-Nelemans, H. C.; Ohnishi, K.; Steegmann, J. L. und Thaler, J.
(2005):
The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha.
In: Haematologica, Bd. 90, Nr. 3: S. 335-340
Hasford, Joerg; Pfirrmann, Markus; Hehlmann, R.; Baccarani, M.; Guilhot, F.; Mahon, F. X.; Kluin-Nelemans, H. C.; Ohnishi, K.; Thaler, J. und Steegmann, J. L.
(2003):
Prognosis and prognostic factors for patients with chronic myeloid leukemia: nontransplant therapy.
In: Seminars in Hematology, Bd. 40, Nr. 1: S. 4-12
Diese Liste wurde am
Sat Dec 21 18:24:23 2024 CET
erstellt.